Pediatric Refractory Partial Status Epilepticus Responsive to Topiramate

Abstract

Topiramate was safely administered to two young children with refractory partial status epilepticus via nasogastric tube in rapid titration up to a very high total daily dose. An excellent clinical response occurred in both cases. Reaching high daily doses of topiramate within days allowed for safe discontinuation of other antiepileptic drugs in both patients. Given the high efficacy of rapidly titrated topiramate in our patients, this medication may be useful in some cases of pediatric refractory partial status epilepticus. However, more clinical studies on this therapeutic approach are needed to establish the precise role of topiramate in status epilepticus in children.( J Child Neurol 2005;20:239—241).

Get full access to this article

View all access options for this article.

References

Mitchell W. : Status epilepticus and acute serial seizures in children. J Child Neurol 2002;17(Suppl 1):S36—S43.

Mayer SA , Claassen J. , Lokin J. , et al. Refractory status epilepticus: Frequency, risk factors, and impact on outcome. Arch Neurol 2002;59:205—210.

Gilbert DL , Gartside PS , Glauser TA : Efficacy and mortality in treatment of refractory generalized convulsive status epilepticus in children: A meta-analysis. J Child Neurol 1999;14:602—609.

Singhi S. , Banerjee S. , Singhi P. : Refractory status epilepticus in children: Role of continuous diazepam infusion . J Child Neurol 1998;13:23—26.

Sahin M. , Menache CC , Holmes GL , Riviello JJ : Outcome of severe refractorystatusepilepticusinchildren. Epilepsia 2001;42:1461—1467.

Kim SJ , Lee DY , Kim JS : Neurologic outcomes of pediatric epileptic patients with pentobarbital coma . Pediatr Neurol 2001; 25:217—220.

Crawford TO , Mitchell WG , Fishman LS , Snodgrass SR : Very-high-dose phenobarbital for refractory status epilepticus in children . Neurology 1988;38:1035—1040.

Hauser WA : Status epilepticus: Epidemiologic consideration. Neurology 1990;40(Suppl 2):9—13.

Maytal J. , Shinnar S. , Moshe SL , Alvarez LA : Low morbidity and mortality of status epilepticus in children. Pediatrics 1989;83: 323—331.

10.

Holmes GL , Riviello J. Jr: Midazolam and pentobarbital for refractory status epilepticus. Pediatr Neurol 1999;20:259—264.

11.

Pellock JM : Use of midazolam for refractory status epilepticus in pediatric patients. J Child Neurol 1998;13:581—587.

12.

Towne AR , Pellock D. , Ko D. , DeLorenzo RJ : Determinants of mortality in status epilepticus. Epilepsia 1994;35:27—34.

13.

Neibauer M. , Gruenthal M. : Topiramate reduces neuronal injury after experimental status epilepticus. Brain Res 1999;837:263—269.

14.

Towne AR , Garnett LK , Waterhouse EJ , et al: The use of topiramate in refractory status epilepticus. Neurology 2003;60:332—334.

15.

Kahriman M. , Minecan D. , Kutluay E. , et al: Efficacy of topiramate in children with Epilepsia 2003;44:1353—1356.

16.

Bleck TP : Advances in the management of refractory status epilepticus. Crit Care Med 1993;21:955—957.

17.

Lowenstein DH , Alldredge BK : Status epilepticus at an urban public hospital in the 1980s. Neurology 1993;43:483—488.

18.

Singhi S. , Murthy A. , Singhi P. , Jayashree M. : Continuous midazolam versus diazepam infusion for refractory convulsive status epilepticus. J Child Neurol 2002;17:106—110.

19.

Bleck PB : Refractory status epilepticus in 2001. Arch Neurol 2002;59:188—189.

20.

Glauser TA , Clarke PO , Strawsburg R. : A pilot study of topiramate in the treatment of infantile spasms. Epilepsia 1998;39:1324—1328.

21.

Watemberg N. , Goldberg-Stern H. , Ben-Zeev B. , et al: Clinical experience with open-label topiramate use in infants younger than 2 years of age. J Child Neurol 2003; 18:258-262.